These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16623659)

  • 1. Highlights in opioid agonists and antagonists.
    Lauretti GR
    Expert Rev Neurother; 2006 Apr; 6(4):613-22. PubMed ID: 16623659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity.
    Sirohi S; Dighe SV; Madia PA; Yoburn BC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):513-9. PubMed ID: 19435929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern pain therapy with dual advantage. Strong analgesia and superior tolerance].
    MMW Fortschr Med; 2009 Apr; 151(18):26. PubMed ID: 19769066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Agonists of opioid receptors may aggravate ischemic and reperfusion damages of the heart].
    Maslov LN; Barzakh EI; Lishmanov AY; Gorbunov AS; Tsybul'nikov SY; Sementsov AS
    Patol Fiziol Eksp Ter; 2014; (1):79-84. PubMed ID: 25051688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
    van Niel JC; Schneider J; Tzschentke TM
    Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Receptors.
    Stein C
    Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in attenuating opioid-induced respiratory depression: A narrative review.
    Fan YZ; Duan YL; Chen CT; Wang Y; Zhu AP
    Medicine (Baltimore); 2024 Jul; 103(29):e38837. PubMed ID: 39029082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy II: narcotic and narcotic-antagonists analgesics.
    Gardier RW
    Dent Clin North Am; 1978 Jan; 22(1):125-41. PubMed ID: 23324
    [No Abstract]   [Full Text] [Related]  

  • 9. Nociceptin, endogenous opioid peptide. Preface.
    Litwack G
    Vitam Horm; 2015; 97():xv-xvi. PubMed ID: 25677779
    [No Abstract]   [Full Text] [Related]  

  • 10. Indications for Opioid Antagonists.
    Coppes OJM; Sang CN
    Curr Pain Headache Rep; 2017 Jun; 21(6):30. PubMed ID: 28547246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the central opioid system as an antidepressant target in rodent models.
    McHugh KL; Kelly JP
    Prog Brain Res; 2018; 239():49-87. PubMed ID: 30314569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
    Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of opioid agonists and antagonists in addiction and pain medicine.
    Leri F
    Expert Opin Pharmacother; 2008 Jun; 9(8):1387-96. PubMed ID: 18473712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effect of MR2266 and MR2267 on morphine or nalbuphine analgesia at the spinal levels in rats.
    Kmieciak-Kołada K; Spiewak Z; Urbanowicz A; Pawłowski J; Herman ZS
    Pol J Pharmacol; 1995; 47(6):509-18. PubMed ID: 8868373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
    Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
    Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the alpha2A-adrenoceptor gene.
    Ozdoğan UK; Lähdesmäki J; Scheinin M
    Eur J Pharmacol; 2006 Jan; 529(1-3):105-13. PubMed ID: 16325800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are peripheral opioid antagonists the solution to opioid side effects?
    Bates JJ; Foss JF; Murphy DB
    Anesth Analg; 2004 Jan; 98(1):116-122. PubMed ID: 14693600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation.
    Carli M; Donnini S; Pellegrini C; Coppi E; Bocci G
    Pharmacol Res; 2020 Sep; 159():104938. PubMed ID: 32504831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.